International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the initiation of immune responses. We found a reduction of both DC subsets in 42 patients with chronic lymphocytic leukaemia (CLL) at diagnosis (P<0.0001 and 0.0001 vs. controls, respectively), likely related to the high secretion of CCL22 and CXCL12 (P=0.04 and 0.008 vs. controls, respectively) by leukaemic cells. However, CD14+ monocytes from CLL patients could give rise to functional IL-12p70-secreting monocyte-derived DCs, capable of inducing a type 1 polarization immunostimulatory profile. These monocyte-derived DCs from CLL patients efficiently migrate in response to CCL19/MIP-3beta chemokine, suggesting that functional autologous DCs can be ...
One cause of morbidity and mortality in chronic lymphocytic leukemia (CLL) is infection, which resul...
Plasmacytoid dendritic cells (pDC) are the main producers of a key T-cell-stimulatory cytokine, IFNα...
Infections with SARS-CoV-2 have been unduly severe in patients with haematological malignancies, in ...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
Dendritic cells (DCs) are the most potent antigen-presenting cells and are therefore an attractive o...
Chronic lymphocytic leukemia (CLL), the most frequent leukemia in the Western world, is characterize...
Chronic lymphocytic leukemia (CLL) results from the relentless accumulation of small mature, slowly ...
Leukemic bcr-abl positive dendritic cells (DCs) are likely to be present in vivo in chronic myelogen...
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5(+)CD19(+) B cells in ...
Myeloid derived suppressor cells (MDSCs) represent a heterogeneous population that shares certain ch...
One cause of morbidity and mortality in chronic lymphocytic leukemia (CLL) is infection, which resul...
Plasmacytoid dendritic cells (pDC) are the main producers of a key T-cell-stimulatory cytokine, IFNα...
Infections with SARS-CoV-2 have been unduly severe in patients with haematological malignancies, in ...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
International audienceMyeloid and plasmacytoid dendritic cells (MDC, PDC) play a key role in the ini...
Dendritic cells (DCs) are the most potent antigen-presenting cells and are therefore an attractive o...
Chronic lymphocytic leukemia (CLL), the most frequent leukemia in the Western world, is characterize...
Chronic lymphocytic leukemia (CLL) results from the relentless accumulation of small mature, slowly ...
Leukemic bcr-abl positive dendritic cells (DCs) are likely to be present in vivo in chronic myelogen...
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5(+)CD19(+) B cells in ...
Myeloid derived suppressor cells (MDSCs) represent a heterogeneous population that shares certain ch...
One cause of morbidity and mortality in chronic lymphocytic leukemia (CLL) is infection, which resul...
Plasmacytoid dendritic cells (pDC) are the main producers of a key T-cell-stimulatory cytokine, IFNα...
Infections with SARS-CoV-2 have been unduly severe in patients with haematological malignancies, in ...